1. Home
  2. TMDX vs WOR Comparison

TMDX vs WOR Comparison

Compare TMDX & WOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • WOR
  • Stock Information
  • Founded
  • TMDX 1998
  • WOR 1955
  • Country
  • TMDX United States
  • WOR United States
  • Employees
  • TMDX N/A
  • WOR N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • WOR Aerospace
  • Sector
  • TMDX Health Care
  • WOR Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • WOR Nasdaq
  • Market Cap
  • TMDX 2.1B
  • WOR 2.0B
  • IPO Year
  • TMDX 2019
  • WOR N/A
  • Fundamental
  • Price
  • TMDX $57.20
  • WOR $41.99
  • Analyst Decision
  • TMDX Buy
  • WOR Sell
  • Analyst Count
  • TMDX 11
  • WOR 2
  • Target Price
  • TMDX $116.10
  • WOR $46.00
  • AVG Volume (30 Days)
  • TMDX 2.6M
  • WOR 352.3K
  • Earning Date
  • TMDX 02-24-2025
  • WOR 12-17-2024
  • Dividend Yield
  • TMDX N/A
  • WOR 1.62%
  • EPS Growth
  • TMDX N/A
  • WOR N/A
  • EPS
  • TMDX 0.94
  • WOR 0.85
  • Revenue
  • TMDX $401,090,000.00
  • WOR $1,166,910,000.00
  • Revenue This Year
  • TMDX $81.61
  • WOR N/A
  • Revenue Next Year
  • TMDX $22.52
  • WOR $3.53
  • P/E Ratio
  • TMDX $61.04
  • WOR $49.20
  • Revenue Growth
  • TMDX 109.09
  • WOR N/A
  • 52 Week Low
  • TMDX $56.03
  • WOR $37.88
  • 52 Week High
  • TMDX $177.37
  • WOR $69.96
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 35.74
  • WOR 59.78
  • Support Level
  • TMDX $58.40
  • WOR $41.15
  • Resistance Level
  • TMDX $67.80
  • WOR $42.39
  • Average True Range (ATR)
  • TMDX 4.59
  • WOR 1.08
  • MACD
  • TMDX -0.27
  • WOR 0.24
  • Stochastic Oscillator
  • TMDX 4.44
  • WOR 83.97

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products sold to consumers, through retail channels, in the tools, outdoor living and celebrations market categories as well as a wide array of specialized building products that serve customers in the residential and non-residential construction markets, including ceiling suspension systems and light gauge metal framing products, as well as wholly-owned and consolidated operations that produce pressurized containment solutions for heating, cooking and cooling applications, among others. It operates under two reportable operating segments: Consumer Products and Building Products. It derives majority of the revenue from Building Products segment.

Share on Social Networks: